The DOI matches its Crossref record; 242 of the 242 references it cites were found in a registry or an index.
Metabolic and Pharmaceutical Aspects of Fluorinated Compounds
Open accessAbstract
The applications of fluorine in drug design continue to expand, facilitated by an improved understanding of its effects on physicochemical properties and the development of synthetic methodologies that are providing access to new fluorinated motifs. In turn, studies of fluorinated molecules are providing deeper insights into the effects of fluorine on metabolic pathways, distribution, and disposition. Despite the high strength of the C-F bond, the departure of fluoride from metabolic intermediates can be facile. This reactivity has been leveraged in the design of mechanism-based enzyme inhibitors and has influenced the metabolic fate of fluorinated compounds. In this Perspective, we summarize the literature associated with the metabolism of fluorinated molecules, focusing on examples where the presence of fluorine influences the metabolic profile. These studies have revealed potentially problematic outcomes with some fluorinated motifs and are enhancing our understanding of how fluorine should be deployed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ricaurte, G. A., Yuan, J., Hatzidimitriou, G., Cord, B. J., & McCann, U. D. (2003) · Science · doi:10.1126/science.301.5639.1479b · Cited by 65
RetractedFluorine in Pharmaceuticals: Looking Beyond Intuition
Müller, K., Faeh, C., & Diederich, F. (2007) · Science · doi:10.1126/science.1131943 · Cited by 6,596
Wang, J., Sánchez-Roselló, M., Aceña, J. L., del Pozo, C., Sorochinsky, A. E., Fustero, S., Soloshonok, V. A., & Liu, H. (2014) · Chemical Reviews · doi:10.1021/cr4002879 · Cited by 4,847
Understanding organofluorine chemistry. An introduction to the C–F bond
O'Hagan, D. (2008) · Chem. Soc. Rev. · doi:10.1039/b711844a · Cited by 4,045
Applications of Fluorine in Medicinal Chemistry
Gillis, E. P., Eastman, K. J., Hill, M. D., Donnelly, D. J., & Meanwell, N. A. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00258 · Cited by 3,618
Self-citationThe Many Roles for Fluorine in Medicinal Chemistry
Hagmann, W. K. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800219f · Cited by 3,578
Bond Dissociation Energies of Organic Molecules
Blanksby, S. J., & Ellison, G. B. (2003) · ChemInform · doi:10.1002/chin.200324299 · Cited by 3,376
Zhou, Y., Wang, J., Gu, Z., Wang, S., Zhu, W., Aceña, J. L., Soloshonok, V. A., Izawa, K., & Liu, H. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00392 · Cited by 2,808
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
Meanwell, N. A. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01788 · Cited by 2,655
Self-citationIntroduction of Fluorine and Fluorine‐Containing Functional Groups
Liang, T., Neumann, C. N., & Ritter, T. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201206566 · Cited by 2,564
Ilardi, E. A., Vitaku, E., & Njardarson, J. T. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401375q · Cited by 1,604
Fluorine in Medicinal Chemistry
Böhm, H., Banner, D., Bendels, S., Kansy, M., Kuhn, B., Müller, K., Obst‐Sander, U., & Stahl, M. (2004) · ChemBioChem · doi:10.1002/cbic.200301023 · Cited by 1,572
C−F Bond Activation in Organic Synthesis
Amii, H., & Uneyama, K. (2009) · Chemical Reviews · doi:10.1021/cr800388c · Cited by 1,549
Yang, X., Wu, T., Phipps, R. J., & Toste, F. D. (2015) · Chemical Reviews · doi:10.1021/cr500277b · Cited by 1,383
The Catalytic Pathway of Cytochrome P450cam at Atomic Resolution
Schlichting, I., Berendzen, J., Chu, K., Stock, A. M., Maves, S. A., Benson, D. E., Sweet, R. M., Ringe, D., Petsko, G. A., & Sligar, S. G. (2000) · Science · doi:10.1126/science.287.5458.1615 · Cited by 1,331
The Unique Role of Fluorine in the Design of Active Ingredients for Modern Crop Protection
Jeschke, P. (2004) · ChemBioChem · doi:10.1002/cbic.200300833 · Cited by 1,325
Aromatic substituent constants for structure-activity correlations
Hansch, C., Leo, A., Unger, S. H., Kim, K. H., Nikaitani, D., & Lien, E. J. (1973) · Journal of Medicinal Chemistry · doi:10.1021/jm00269a003 · Cited by 1,262
Irreversible Inhibitors of Serine, Cysteine, and Threonine Proteases
Powers, J. C., Asgian, J. L., Ekici, Ö. D., & James, K. E. (2002) · Chemical Reviews · doi:10.1021/cr010182v · Cited by 1,090
Effects of anacetrapib in patients with atherosclerotic vascular disease
The HPS3/TIMI55–REVEAL Collaborative Group (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1706444 · Cited by 1,047
Metcalf, B. W., Bey, P., Danzin, C., Jung, M. J., Casara, P., & Vevert, J. P. (1978) · Journal of the American Chemical Society · doi:10.1021/ja00476a050 · Cited by 1,004
A perspective of polyamine metabolism
WALLACE, H. M., FRASER, A. V., & HUGHES, A. (2003) · Biochemical Journal · doi:10.1042/bj20031327 · Cited by 929
Successful fluorine-containing herbicide agrochemicals
Fujiwara, T., & O’Hagan, D. (2014) · Journal of Fluorine Chemistry · doi:10.1016/j.jfluchem.2014.06.014 · Cited by 894
Ahrens, T., Kohlmann, J., Ahrens, M., & Braun, T. (2015) · Chemical Reviews · doi:10.1021/cr500257c · Cited by 843
Polyamine metabolism and cancer: treatments, challenges and opportunities
Casero, R. A., Murray Stewart, T., & Pegg, A. E. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0050-3 · Cited by 817
THE CATALYTIC MECHANISM AND STRUCTURE OF THYMIDYLATE SYNTHASE
Carreras, C. W., & Santi, D. V. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.003445 · Cited by 768
Monoamine oxidase inactivation: from pathophysiology to therapeutics
Bortolato, M., Chen, K., & Shih, J. C. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.06.002 · Cited by 634
Metabolism of Fluorine-Containing Drugs
Park, B. K., Kitteringham, N. R., & O'Neill, P. M. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.443 · Cited by 610
Recent advances (1995–2005) in fluorinated pharmaceuticals based on natural products
Bégué, J.-P., & Bonnet-Delpon, D. (2006) · Journal of Fluorine Chemistry · doi:10.1016/j.jfluchem.2006.05.006 · Cited by 600
The unique role of halogen substituents in the design of modern agrochemicals
Jeschke, P. (2010) · Pest Management Science · doi:10.1002/ps.1829 · Cited by 593
Salmonella mutagenicity tests: V. Results from the testing of 311 chemicals
Zeiger, E., Anderson, B., Haworth, S. R., Lawlor, T. E., & Mortelmans, K. E. (1992) · Environmental and Molecular Mutagenesis · doi:10.1002/em.2850190603 · Cited by 573
Hansch, C., Muir, R. M., Fujita, T., Maloney, P. P., Geiger, F., & Streich, M. (1963) · Journal of the American Chemical Society · doi:10.1021/ja00901a033 · Cited by 514
RECENT ADVANCES IN FLUORINATED PHARMACEUTICALS BASED ON NATURAL PRODUCTS
Hai-tao, Y. (2006) · Cited by 483
Difluoromethylation Reactions of Organic Compounds
Yerien, D. E., Barata‐Vallejo, S., & Postigo, A. (2017) · Chemistry - A European Journal · doi:10.1002/chem.201702311 · Cited by 455
Complex reactions catalyzed by cytochrome P450 enzymes
Isin, E. M., & Guengerich, F. P. (2007) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2006.07.003 · Cited by 448
Baeyer−Villiger Monooxygenases: More Than Just Green Chemistry
Leisch, H., Morley, K., & Lau, P. C. K. (2011) · Chemical Reviews · doi:10.1021/cr1003437 · Cited by 443
Selective inhibitors of biosynthesis of aminergic neurotransmitters
KOLLONITSCH, J., PATCHETT, A. A., MARBURG, S., MAYCOCK, A. L., PERKINS, L. M., DOLDOURAS, G. A., DUGGAN, D. E., & ASTER, S. D. (1978) · Nature · doi:10.1038/274906a0 · Cited by 423
Polytetrafluoroethylene: Synthesis and Characterization of the Original Extreme Polymer
Puts, G. J., Crouse, P., & Ameduri, B. M. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00458 · Cited by 416
Mechanistic insights into glycosidase chemistry
Vocadlo, D. J., & Davies, G. J. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2008.05.010 · Cited by 404
LIPPERT, B., METCALF, B. W., JUNG, M. J., & CASARA, P. (1977) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1977.tb11410.x · Cited by 378
Phillips, M. A., Lotharius, J., Marsh, K., White, J., Dayan, A., White, K. L., Njoroge, J. W., El Mazouni, F., Lao, Y., Kokkonda, S., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa6645 · Cited by 371
Acetaldehyde adducts in alcoholic liver disease
Setshedi, M., Wands, J. R., & de la Monte, S. M. (2010) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.3.3.12288 · Cited by 365
The p KBHX Database: Toward a Better Understanding of Hydrogen-Bond Basicity for Medicinal Chemists
Laurence, C., Brameld, K. A., Graton, J., Le Questel, J.-Y., & Renault, E. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801331y · Cited by 346
Enzymatic fluorination and biotechnological developments of the fluorinase
O’Hagan, D., & Deng, H. (2015) · Chemical Reviews · doi:10.1021/cr500209t · Cited by 331
THE DISPOSITION OF VORICONAZOLE IN MOUSE, RAT, RABBIT, GUINEA PIG, DOG, AND HUMAN
Roffey, S. J., Cole, S., Comby, P., Gibson, D., Jezequel, S. G., Nedderman, A. N. R., Smith, D. A., Walker, D. K., & Wood, N. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.6.731 · Cited by 330
Fluoride: a Review of Use and Effects on Health
Kanduti, D., Sterbenk, P., & Artnik, A. (2016) · Materia Socio Medica · doi:10.5455/msm.2016.28.133-137 · Cited by 301
Formation and Cleavage of C–C Bonds by Enzymatic Oxidation–Reduction Reactions
Guengerich, F. P., & Yoshimoto, F. K. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00031 · Cited by 296
Cell-surface enzymes in control of leukocyte trafficking
Salmi, M., & Jalkanen, S. (2005) · Nature Reviews Immunology · doi:10.1038/nri1705 · Cited by 281
Fluorine in Medicinal Chemistry
Swallow, S. (2015) · Progress in Medicinal Chemistry · doi:10.1016/bs.pmch.2014.11.001 · Cited by 280
Bertelsen, K. M., Venkatakrishnan, K., von Moltke, L. L., Obach, R. S., & Greenblatt, D. J. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.3.289 · Cited by 276
Nielsen, O. J., Javadi, M. S., Sulbaek Andersen, M. P., Hurley, M. D., Wallington, T. J., & Singh, R. (2007) · Chemical Physics Letters · doi:10.1016/j.cplett.2007.03.053 · Cited by 253
Latest generation of halogen‐containing pesticides
Jeschke, P. (2017) · Pest Management Science · doi:10.1002/ps.4540 · Cited by 252
Huchet, Q. A., Kuhn, B., Wagner, B., Kratochwil, N. A., Fischer, H., Kansy, M., Zimmerli, D., Carreira, E. M., & Müller, K. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01455 · Cited by 239
Inhalation toxicity of acetaldehyde in rats. III. Carcinogenicity study
Woutersen, R. A., Appelman, L. M., Van Garderen-Hoetmer, A., & Feron, V. J. (1986) · Toxicology · doi:10.1016/0300-483x(86)90201-5 · Cited by 234
Reaction of Sevoflurane and Its Degradation Products with Soda Lime: Toxicity of the Byproducts
Morio, M., Fujii, K., Satoh, N., Imai, M., Kawakami, U., Mizuno, T., Kawai, Y., Ogasawara, Y., Tamura, T., Negishi, A., et al. (1992) · Anesthesiology · doi:10.1097/00000542-199212000-00017 · Cited by 232
A nontoxic pain killer designed by modeling of pathological receptor conformations
Spahn, V., Del Vecchio, G., Labuz, D., Rodriguez-Gaztelumendi, A., Massaly, N., Temp, J., Durmaz, V., Sabri, P., Reidelbach, M., Machelska, H., et al. (2017) · Science · doi:10.1126/science.aai8636 · Cited by 229
Pan, Y., Qiu, J., & Silverman, R. B. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm034162s · Cited by 228
Ot’alora G, M., Grigsby, J., Poulter, B., Van Derveer, J. W., Giron, S. G., Jerome, L., Feduccia, A. A., Hamilton, S., Yazar-Klosinski, B., Emerson, A., et al. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118806297 · Cited by 226
Xu, R., Wang, K., Rizzi, J. P., Huang, H., Grina, J. A., Schlachter, S. T., Wang, B., Wehn, P. M., Yang, H., Dixon, D. D., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00719 · Cited by 220
Kenna, J. G., Satoh, H., Christ, D. D., & Pohl, L. R. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24104-0 · Cited by 209
Vaz, A. D., Pernecky, S. J., Raner, G. M., & Coon, M. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.4644 · Cited by 200
Human Cytochrome P450 2E1 Is a Major Autoantigen Associated with Halothane Hepatitis
Bourdi, M., Chen, W., Peter, R. M., Martin, J. L., Buters, J. T. M., Nelson, S. D., & Pohl, L. R. (1996) · Chemical Research in Toxicology · doi:10.1021/tx960083q · Cited by 189
Kharasch, E. D., Armstrong, A. S., Gunn, K., Artru, A., Cox, K., & Karol, M. D. (1995) · Anesthesiology · doi:10.1097/00000542-199506000-00009 · Cited by 176
Aqueous Photochemical Reaction Kinetics and Transformations of Fluoxetine
Lam, M. W., Young, C. J., & Mabury, S. A. (2005) · Environmental Science & Technology · doi:10.1021/es0494757 · Cited by 171
An Animal Model of Halothane Hepatotoxicity: Roles of Enzyme Induction and Hypoxia
McLain, G. E., Sipes, I. G., & Brown, B. R. (1979) · Anesthesiology · doi:10.1097/00000542-197910000-00008 · Cited by 167
Shan, B., Medina, J. C., Santha, E., Frankmoelle, W. P., Chou, T.-C., Learned, R. M., Narbut, M. R., Stott, D., Wu, P., Jaen, J. C., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5686 · Cited by 164
Biotransformation of Sevoflurane
Kharasch, E. D. (1995) · Anesthesia & Analgesia · doi:10.1097/00000539-199512001-00005 · Cited by 162
Lee, K. L., Ambler, C. M., Anderson, D. R., Boscoe, B. P., Bree, A. G., Brodfuehrer, J., Chang, J. S., Choi, C., Chung, S., Curran, K. J., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00231 · Cited by 162
Cox, C. D., Coleman, P. J., Breslin, M. J., Whitman, D. B., Garbaccio, R. M., Fraley, M. E., Buser, C. A., Walsh, E. S., Hamilton, K., Schaber, M. D., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800386y · Cited by 160
Suicide substrates for the alanine racemase of Escherichia coli B
Wang, E., & Walsh, C. T. (1978) · Biochemistry · doi:10.1021/bi00600a028 · Cited by 156
Fluorine in Drug Design: A Case Study with Fluoroanisoles
Li, X., Blakemore, D. C., Narayanan, A., Unwalla, R. J., Lovering, F., Denny, R. A., Zhou, H., & Bunnage, M. E. (2015) · ChemMedChem · doi:10.1002/cmdc.201402555 · Cited by 155
Drug Discovery Targeting Amino Acid Racemases
Conti, P., Tamborini, L., Pinto, A., Blondel, A., Minoprio, P. M. C., Mozzarelli, A., & Micheli, C. D. (2011) · Chemical Reviews · doi:10.1021/cr2000702 · Cited by 155
Storici, P., Biase, D. D., Bossa, F., Bruno, S., Mozzarelli, A., Peneff, C., Silverman, R. B., & Schirmer, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305884200 · Cited by 152
Application of the Pentafluorosulfanyl Group as a Bioisosteric Replacement
Sowaileh, M. F., Hazlitt, R. A., & Colby, D. A. (2017) · ChemMedChem · doi:10.1002/cmdc.201700356 · Cited by 151
Effects of Fluorine Substitution on Drug Metabolism: Pharmacological and Toxicological Implications
Park, B. K., & Kitteringham, N. R. (1994) · Drug Metabolism Reviews · doi:10.3109/03602539408998319 · Cited by 150
Clinical Pharmacokinetics of Sevoflurane
Behne, M., Wilke, H., & Harder, S. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199936010-00002 · Cited by 147
Potential fluoride toxicity from oral medicaments: A review.
Ullah, R., Zafar, M. S., & Shahani, N. (2017) · PubMed · doi:10.22038/ijbms.2017.9104 · Cited by 147
Murray, M. (2000) · Current Drug Metabolism · doi:10.2174/1389200003339270 · Cited by 145
Dc, R., & Drummond, G. B. (1991) · British Journal of Anaesthesia · doi:10.1093/bja/67.1.84 · Cited by 145
Shaw, E. N., Bernstein, J., Losee, K. A., & Lott, W. A. (1950) · Journal of the American Chemical Society · doi:10.1021/ja01166a008 · Cited by 144
Nodwell, M. B., Yang, H., Čolović, M., Yuan, Z., Merkens, H., Martin, R. E., Bénard, F., Schaffer, P. C., & Britton, R. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.6b11533 · Cited by 143
Polyfluorinated Ethanes as Versatile Fluorinated C2-Building Blocks for Organic Synthesis
Nenajdenko, V. G., Muzalevskiy, V. M., & Shastin, A. V. (2015) · Chemical Reviews · doi:10.1021/cr500465n · Cited by 140
Pettersson, M., Hou, X., Kühn, M., Wager, T. T., Kauffman, G. W., & Verhoest, P. R. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00027 · Cited by 140
The mechanism of reductive dehalogenation of halothane by liver cytochrome P450
Ahr, H. J., King, L. J., Nastainczyk, W., & Ullrich, V. (1982) · Biochemical Pharmacology · doi:10.1016/0006-2952(82)90186-1 · Cited by 135
Pan, Y. (2019) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00235 · Cited by 134
SAR and Mode of Action of Novel Non-Nucleoside Inhibitors of Hepatitis C NS5b RNA Polymerase
Powers, J. P., Piper, D. E., Li, Y., Mayorga, V., Anzola, J. V., Chen, J., Jaén, J. C., Lee, G., Liu, J., Peterson, M. G., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm050859x · Cited by 131
Clinical Sevoflurane Metabolism and Disposition
Kharasch, E. D., Karol, M. D., Lanni, C., & Sawchuk, R. (1995) · Anesthesiology · doi:10.1097/00000542-199506000-00008 · Cited by 130
Sodium Fluoroacetate Poisoning
Proudfoot, A. T., Bradberry, S., & Vale, J. A. (2006) · Toxicological Reviews · doi:10.2165/00139709-200625040-00002 · Cited by 129
Fluoride Excess and Periostitis in Transplant Patients Receiving Long-Term Voriconazole Therapy
Wermers, R. A., Cooper, K., Razonable, R. R., Deziel, P. J., Whitford, G. M., Kremers, W. K., & Moyer, T. P. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq188 · Cited by 127
Decarboxylation mechanisms in biological system
Li, T., Huo, L., Pulley, C., & Liu, A. (2012) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2012.03.001 · Cited by 126
Toxicology of fluoroacetate: a review, with possible directions for therapy research
Goncharov, N. V., Jenkins, R. O., & Radilov, A. S. (2005) · Journal of Applied Toxicology · doi:10.1002/jat.1118 · Cited by 125
McCarthy, J. S., Lotharius, J., Rückle, T., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30171-8 · Cited by 123
Lin, L. S., Lanza, T. J., Jewell, J. P., Liu, P., Shah, S. K., Qi, H., Tong, X., Wang, J., Xu, S. S., Fong, T. M., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060996+ · Cited by 122
Lauble, H., Kennedy, M. C., Emptage, M. H., Beinert, H., & Stout, C. D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13699 · Cited by 121
Fischer, R. T., Trzaskos, J. M., Magolda, R. L., Ko, S. S., Brosz, C. S., & Larsen, B. S. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)38093-1 · Cited by 120
Edmondson, S. D., Mastracchio, A., Mathvink, R. J., He, J., Harper, B., Park, Y., Beconi, M. G., Salvo, J. D., Eiermann, G. J., He, H., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060015t · Cited by 120
Welch, J. T., & Lim, D. S. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.08.012 · Cited by 118
Synthesis and biological evaluation of the first pentafluorosulfanyl analogs of mefloquine
Wipf, P., Mo, T., Geib, S. J., Caridha, D. P., Dow, G. S., Gerena, L., Roncal, N. E., & Milner, E. (2009) · Organic & Biomolecular Chemistry · doi:10.1039/b911483a · Cited by 116
Mechanism of Enzymatic Fluorination in Streptomyces c attleya
Zhu, X., Robinson, D. A., McEwan, A. R., O’Hagan, D., & Naismith, J. H. (2007) · Journal of the American Chemical Society · doi:10.1021/ja0731569 · Cited by 114
Tong, Z., Philip G. Board, & Anders, M. W. (1998) · Chemical Research in Toxicology · doi:10.1021/tx980144f · Cited by 114
18 F‐Labeling of Sensitive Biomolecules for Positron Emission Tomography
Krishnan, H. S., Ma, L., Vasdev, N., & Liang, S. H. (2017) · Chemistry - A European Journal · doi:10.1002/chem.201701581 · Cited by 112
Diana, G. D., Rudewicz, P. J., Pevear, D. C., Nitz, T. J., Aldous, S. C., Aldous, D., Robinson, D. T., Draper, T. L., Dutko, F. J., Aldi, C., et al. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00008a014 · Cited by 108
Fluorometabolite biosynthesis and the fluorinase from Streptomyces cattleya
Deng, H., O’Hagan, D., & Schaffrath, C. (2004) · Natural Product Reports · doi:10.1039/b415087m · Cited by 108
Mapping the reaction coordinates of enzymatic defluorination
Chan, P. W. Y., Yakunin, A. F., Edwards, E. A., & Pai, E. F. (2011) · Journal of the American Chemical Society · doi:10.1021/ja200277d · Cited by 107
Squalene epoxidase as a promising metabolic target in cancer treatment
Cirmena, G., Franceschelli, P., Isnaldi, E., Ferrando, L., Mariano, M. D., Ballestrero, A., & Zoppoli, G. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.03.034 · Cited by 105
Krauser, J. A., & Guengerich, F. P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501854200 · Cited by 104
Inhalation toxicity of acetaldehyde in rats. I. Acute and subacute studies
Appelman, L. M., Woutersen, R. A., & Feron, V. J. (1982) · Toxicology · doi:10.1016/0300-483x(82)90068-3 · Cited by 101
de Montellano, P. R. O., Kunze, K. L., Beilan, H. S., & Wheeler, C. R. (1982) · Biochemistry · doi:10.1021/bi00535a035 · Cited by 99
Changes in tropospheric composition and air quality
Tang, X., Madronich, S., Wallington, T. J., & Calamari, D. (1998) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/s1011-1344(98)00187-0 · Cited by 99
Li, P., Zheng, H., Zhao, J., Zhang, L., Yao, W., Zhu, H., Beard, J. D., Ida, K., Lane, W., Snell, G., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01751 · Cited by 98
Neoantigens Associated with Halothane Hepatitis
Pohl, L. R., Kenna, J. G., Satoh, H., Christ, D. D., & Martin, J. L. (1989) · Drug Metabolism Reviews · doi:10.3109/03602538909103537 · Cited by 94
Murphy, C. D., & Sandford, G. (2015) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2015.1020295 · Cited by 93
Berkowitz, D. B., Karukurichi, K. R., de la Salud‐Bea, R., Nelson, D. L., & McCune, C. D. (2008) · Journal of Fluorine Chemistry · doi:10.1016/j.jfluchem.2008.05.016 · Cited by 92
Catalytic mechanism of C–F bond cleavage: insights from QM/MM analysis of fluoroacetate dehalogenase
Li, Y., Zhang, R., Du, L., Zhang, Q., & Wang, W. (2015) · Catalysis Science & Technology · doi:10.1039/c5cy00777a · Cited by 92
Kuo, E., Hambleton, P. T., Kay, D. P., Evans, P. L., Matharu, S. S., Little, E., McDowall, N., Jones, C. B., Hedgecock, C. J. R., Yea, C., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm9604437 · Cited by 91
Acute effects of exposure to vapours of acetic acid in humans
Ernstgård, L., Iregren, A., Sjögren, B., & Johanson, G. (2006) · Toxicology Letters · doi:10.1016/j.toxlet.2006.01.010 · Cited by 89
Insight into Enzymatic C−F Bond Formation from QM and QM/MM Calculations
Senn, H. M., O’Hagan, D., & Thiel, W. (2005) · Journal of the American Chemical Society · doi:10.1021/ja053875s · Cited by 88
Design and Mechanism of GABA Aminotransferase Inactivators. Treatments for Epilepsies and Addictions
Silverman, R. B. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00009 · Cited by 88
A review of major chlorofluorocarbons and their halocarbon alternatives in the air
Kim, K., Shon, Z., Nguyen, H. T., & Jeon, E.-C. (2010) · Atmospheric Environment · doi:10.1016/j.atmosenv.2010.12.029 · Cited by 87
Periostitis Secondary to Prolonged Voriconazole Therapy in Lung Transplant Recipients
Wang, T. F., Wang, T., Altman, R. D., Eshaghian, P., Lynch, J. P., Ross, D. J., Belperio, J. A., WEIGT, S. S., Saggar, R., Gregson, A. L., et al. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02837.x · Cited by 87
Human liver microsomal enflurane defluorination catalyzed by cytochrome P-450 2E1.
Thummel, K. E., Kharasch, E. D., Podoll, T., et al. (1993) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08102-4 · Cited by 87
Gotto, A. M., Cannon, C. P., Li, X. S., Vaidya, S., Kher, U., Brinton, E. A., Davidson, M., Moon, J. E., Shah, S., Dansky, H. M., et al. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.08.041 · Cited by 86
Enzyme inhibition by fluoro compounds.
Abeles, R. H., & Alston, T. A. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44813-7 · Cited by 85
Cytochrome P450-Catalyzed Oxidation of Halobenzene Derivatives
Rietjens, I. M. C. M., den Besten, C., Hanzlik, R. P., & van BLADEREN, P. J. (1997) · Chemical Research in Toxicology · doi:10.1021/tx9601061 · Cited by 84
Thymidylate synthetase. Model studies of inhibition by 5-trifluoromethyl-2'-deoxyuridylic acid
Santi, D. V., & Sakai, T. T. (1971) · Biochemistry · doi:10.1021/bi00795a018 · Cited by 83
Novel insights into the complex pharmacokinetics of voriconazole: a review of its metabolism
Schulz, J., Kluwe, F., Mikus, G., Michelet, R., & Kloft, C. (2019) · Drug Metabolism Reviews · doi:10.1080/03602532.2019.1632888 · Cited by 83
Metabolic Pathways of Inhaled Glucocorticoids by the CYP3A Enzymes
Moore, C. D., Roberts, J. K., Orton, C. R., Murai, T., Fidler, T. P., Reilly, C. A., Ward, R. M., & Yost, G. S. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.046318 · Cited by 80
Inactivation of pyridoxal phosphate dependent enzymes by mono- and polyhaloalanines
Silverman, R. B., & Abeles, R. H. (1976) · Biochemistry · doi:10.1021/bi00666a028 · Cited by 78
Moretto, N., Caruso, P. L., Bosco, R., Marchini, G., Pastore, F., Armani, E., Amari, G., Rizzi, A., Ghidini, E., Fanti, R. D., et al. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.220541 · Cited by 78
Samuel, K., Yin, W., Stearns, R. A., Tang, Y. S., Chaudhary, A., Jewell, J. P., Lanza, T. J., Lin, L. S., Hagmann, W. K., Evans, D. C., et al. (2003) · Journal of Mass Spectrometry · doi:10.1002/jms.434 · Cited by 77
Stability of Sevoflurane in Soda Lime
Strum, D. P., Johnson, B. H., & Eger, E. I. (1987) · Anesthesiology · doi:10.1097/00000542-198711000-00024 · Cited by 76
Self-citationMechanism-based Fluorescent Labeling of β-Galactosidases
Kurogochi, M., Nishimura, S., & Lee, Y. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401718200 · Cited by 75
Arellano, M., Malet‐Martino, M., Martino, R., & Gires, P. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.12 · Cited by 75
LoGiudice, N., Le, L. N.-H., Abuan, I., Leizorek, Y., & Roberts, S. C. (2018) · Medical Sciences · doi:10.3390/medsci6010012 · Cited by 73
Richard, A. M., & Hunter, E. S. (1996) · Teratology · doi:10.1002/(sici)1096-9926(199606)53:6<352::aid-tera6>3.0.co;2-1 · Cited by 72
Neuberger, J., Mieli‐Vergani, G., Tredger, J. M., Davis, M. R., & Williams, R. L. (1981) · Gut · doi:10.1136/gut.22.8.669 · Cited by 72
Mattei, P., Boehringer, M., Giorgio, P. D., Fischer, H., Hennig, M., Huwyler, J., Koçer, B., Kuhn, B., Loeffler, B. M., MacDonald, A., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.12.024 · Cited by 71
The fluorinase, the chlorinase and the duf-62 enzymes
Deng, H., & O’Hagan, D. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2008.06.036 · Cited by 71
Discovery of Fluoromethylketone-Based Peptidomimetics as Covalent ATG4B (Autophagin-1) Inhibitors
Qiu, Z., Kuhn, B., Aebi, J. D., Lin, X., Ding, H., Zhou, Z., Xu, Z., Xu, D., Han, L., Liu, C., et al. (2016) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.6b00208 · Cited by 70
5-Fluorouracil Derivatives from the Sponge Phakellia fusca
Xu, X., Yao, G., Li, Y., Lu, J.-H., Lin, C., Wang, X., & Kong, C. (2003) · Journal of Natural Products · doi:10.1021/np020034f · Cited by 69
Preclinical Characterization of the FAAH Inhibitor JNJ-42165279
Keith, J. M., Jones, W. M., Tichenor, M. S., Liu, J., Seierstad, M. J., Palmer, J. A., Webb, M., Karbarz, M. J., Scott, B. P., Wilson, S. J., et al. (2015) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5b00353 · Cited by 69
Biocatalytic Characterization of Human FMO5: Unearthing Baeyer–Villiger Reactions in Humans
Fiorentini, F., Geier, M., Binda, C., Winkler, M., Faber, K., Hall, M., & Mattevi, A. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.5b01016 · Cited by 69
Deniau, G. P., Slawin, A. M. Z., Lébl, T., Chorki, F., Issberner, J., van Mourik, T., Heygate, J. M., Lambert, J. J., Etherington, L.-A., Sillar, K. T., et al. (2007) · ChemBioChem · doi:10.1002/cbic.200700371 · Cited by 68
Wang, E. A., & Walsh, C. T. (1981) · Biochemistry · doi:10.1021/bi00529a032 · Cited by 65
Murphy, C. D., O’Hagan, D., & Schaffrath, C. (2001) · Angewandte Chemie International Edition · Cited by 64
Snyder, G. L., Prickaerts, J., Wadenberg, M.-L., Zhang, L., Zheng, H., Yao, W., Akkerman, S., Zhu, H., Hendrick, J. P., Vanover, K. E., et al. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4346-2 · Cited by 64
Eckstein, J. W., Foster, P., Finer-Moore, J. S., Wataya, Y., & Santi, D. V. (1994) · Biochemistry · doi:10.1021/bi00254a018 · Cited by 61
McCune, C. D., Beio, M. L., Sturdivant, J. M., de la Salud‐Bea, R., Darnell, B. M., & Berkowitz, D. B. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b04690 · Cited by 58
O’Rourke, A. M., Wang, E. Y., Miller, A., Podar, E. M., Scheyhing, K., Huang, L., Kessler, C., Gao, H., Ton‐Nu, H., MacDonald, M., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.131672 · Cited by 57
Shirasaka, T., Murakami, K., Ford, H., Kelley, J. A., YOSHIOKA, H., Kojima, E., Aoki, S., Broder, S., & Mitsuya, H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.23.9426 · Cited by 57
Chalcogen OCF3 Isosteres Modulate Drug Properties without Introducing Inherent Liabilities
Ghiazza, C., Billard, T., Dickson, C. J., et al. (2019) · ChemMedChem · doi:10.1002/cmdc.201900452 · Cited by 56
BIOTRANSFORMATION OF FLUTICASONE: IN VITRO CHARACTERIZATION
Pearce, R. E., Leeder, J. S., & Kearns, G. L. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.009043 · Cited by 55
Lehmann, A., Antonsson, M., Holmberg, A. A., et al. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.153593 · Cited by 55
Shetty, H. U., Zoghbi, S. S., Siméon, F. G., Liow, J., Brown, A. K., Kannan, P., Innis, R. B., & Pike, V. W. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.143347 · Cited by 54
Reddy, M. C. M., Gokulan, K., Shetty, N. D., Owen, J. L., Ioerger, T. R., & Sacchettini, J. C. (2008) · Protein Science · doi:10.1110/ps.038125.108 · Cited by 54
Kirsten, E., Sharma, M. L., & Kun, E. (1979) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13798-x · Cited by 54
Squalene monooxygenase - a target for hypercholesterolemic therapy
Belter, A., Skupińska, M., Giel-Pietraszuk, M., Grabarkiewicz, T., Rychlewski, L., & Barciszewski, J. (2011) · Biological Chemistry · doi:10.1515/bc.2011.195 · Cited by 53
Purification and partial characterization of squalene epoxidase from rat liver microsomes
Ono, T., Nakazono, K., & KOSAKA, H. (1982) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(82)90424-1 · Cited by 53
Pan, Y., Gerasimov, M. R., Kvist, T., Wellendorph, P., Madsen, K. K., Pera, E., Lee, H., Schousboe, A., Chebib, M., Bräuner‐Osborne, H., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm201231w · Cited by 53
Yang, J., Li, Y., Yan, W., Li, W., Qiu, Q., Ye, H., & Chen, L. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006325 · Cited by 53
Dossetter, A. G. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.04.077 · Cited by 52
Malamas, M. S., Robichaud, A. J., Erdei, J., Quagliato, D. A., Solvibile, W. R., Zhou, P. H., Morris, K., Turner, J., Wagner, E. J., Fan, K. Y., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.09.029 · Cited by 52
Okamura, T., Kikuchi, T., Okada, M., Toramatsu, C., Fukushi, K., Takei, M., & Irie, T. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2008.135 · Cited by 52
Malet‐Martino, M., Gilard, V., Desmoulin, F., & Martino, R. (2005) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.10.013 · Cited by 52
Green, J., Cao, J., Bandarage, U. K., Gao, H., Court, J. J., Marhefka, C. A., Jacobs, M. D., Taslimi, P. M., Newsome, D., Nakayama, T., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00424 · Cited by 52
Karadzovska, D., Seewald, W., Browning, A., Smal, M. A., Bouvier, J., & Giraudel, J. M. (2009) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/j.1365-2885.2008.01052.x · Cited by 51
Davies, C., Chaney, J., Korbel, G. A., Ringe, D., Petsko, G. A., Ploegh, H. L., & Das, C. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.04.124 · Cited by 51
Jin, L., Davis, M. R., Kharasch, E. D., Doss, G. A., & Baillie, T. A. (1996) · Chemical Research in Toxicology · doi:10.1021/tx950162m · Cited by 51
Structural and Mechanistic Studies of Mofegiline Inhibition of Recombinant Human Monoamine Oxidase B
Milczek, E. M., Bonivento, D., Binda, C., Mattevi, A., McDonald, I. A., & Edmondson, D. E. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8011867 · Cited by 50
Jitsumori, K., Omi, R., Kurihara, T., Kurata, A., Mihara, H., Miyahara, I., Hirotsu, K., & Esaki, N. (2009) · Journal of Bacteriology · doi:10.1128/jb.01654-08 · Cited by 50
Zhang, N., Zhang, X., Zhu, J., Turpoff, A., Chen, G., Morrill, C., Huang, S., Lennox, W., Kakarla, R., Liu, R., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401621g · Cited by 50
Tecle, B., & Casida, J. E. (1989) · Chemical Research in Toxicology · doi:10.1021/tx00012a012 · Cited by 49
Leach, A. G., & Kidley, N. J. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci2000506 · Cited by 49
Pike, V. W., Halldin, C., Wikström, H., Marchais, S., McCarron, J. A., Sandell, J., Nowicki, B., Swahn, C.-G., Osman, S., Hume, S. P., et al. (2000) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(00)00110-4 · Cited by 49
Ward, S. E., Harries, M. H., Aldegheri, L., Andreotti, D., Ballantine, S. P., Bax, B. D., Harris, A. J., Harker, A. J., Lund, J., Melarange, R. A., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm1005429 · Cited by 47
Kamachi, T., Nakayama, T., Shitamichi, O., Jitsumori, K., Kurihara, T., Esaki, N., & Yoshizawa, K. (2009) · Chemistry – A European Journal · doi:10.1002/chem.200801813 · Cited by 47
Sherley, M. (2004) · Toxicology Letters · doi:10.1016/j.toxlet.2004.03.013 · Cited by 47
Ndubaku, C. O., Crawford, T. D., Chen, H., Boggs, J. W., Drobnick, J., Harris, S. F., Jesudason, R., McNamara, E., Nonomiya, J., Sambrone, A., et al. (2015) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5b00174 · Cited by 47
Wang, X., Blackaby, W., Allen, V., Chan, G. K. Y., Chang, J. H., Chiang, P., Diène, C. R., Drummond, J., Do, S., Fan, E., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01857 · Cited by 47
Metabolism and Disposition of Fluticasone Furoate, an Enhanced-Affinity Glucocorticoid, in Humans
Hughes, S. C., Shardlow, P. C., Hollis, F. J., Scott, R. J., Motivaras, D. S., Allen, A., & Rousell, V. M. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.022137 · Cited by 46
Schmidt, F., Wenzel, J., Halland, N., Güssregen, S., Delafoy, L., & Czich, A. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00338 · Cited by 45
Pohl, L. R. (1993) · Chemical Research in Toxicology · doi:10.1021/tx00036a006 · Cited by 44
Perfetti, X., O’Mathúna, B., Pizarro, N., Cuyàs, E., Khymenets, O., Almeida, B., Pellegrini, M., Pichini, S., Lau, S. S., Monks, T. J., et al. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.026393 · Cited by 43
Hendriks, C. M. M., Penning, T. M., Zang, T., Wiemuth, D., Gründer, S., Sanhueza, I. A., Schoenebeck, F., & Bolm, C. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.09.012 · Cited by 42
Novel Roflumilast analogs as soft PDE4 inhibitors
Boland, S., Alen, J., Bourin, A., Castermans, K., Boumans, N., Panitti, L., Vanormelingen, J., Leysen, D. C., & Defert, O. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.07.016 · Cited by 42
Laine, K., Anttila, M. I., Helminen, A., Karnani, H., & Huupponen, R. (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00891.x · Cited by 42
Levin, V. A., Ictech, S. E., & Hess, K. R. (2018) · CNS Oncology · doi:10.2217/cns-2017-0031 · Cited by 42
Lee, Y.-S. E., Chuang, S., Huang, L. Y. L., Lai, C., Lin, Y., Yang, J., Liu, C.-W., Yang, S., Lin, H.-S., Chang, C., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401990s · Cited by 41
Monofluoroacetate-Containing Plants That Are Potentially Toxic to Livestock
Lee, S. T., Cook, D., Pfister, J. A., Allen, J. G., Colegate, S. M., Riet-Corrêa, F., & Taylor, C. M. (2014) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf500563h · Cited by 41
Zhou, Z., Ge, B.-C., Zhong, Q., Huang, C., Cheng, Y., Yang, X., Wang, H., & Xu, J. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.08.052 · Cited by 41
Timperley, C. M. (2004) · Journal of Fluorine Chemistry · doi:10.1016/j.jfluchem.2003.11.021 · Cited by 40
Barnes, G. B., Mariani, B. D., & Tuan, R. S. (1996) · Teratology · doi:10.1002/(sici)1096-9926(199606)54:2<57::aid-tera1>3.0.co;2-1 · Cited by 39
Johnson, C. M., Linsky, T. W., Yoon, D.-W., Person, M. D., & Fast, W. L. (2011) · Journal of the American Chemical Society · doi:10.1021/ja109207m · Cited by 39
Morgan, M. E., Chi, S. C., Murakami, K., Mitsuya, H., & Anderson, B. D. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.10.2156 · Cited by 38
Baeyer–Villiger Monooxygenase FMO5 as Entry Point in Drug Metabolism
Fiorentini, F., Romero, E., Fraaije, M. W., Faber, K., Hall, M., & Mattevi, A. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00470 · Cited by 38
METABOLIC ACTIVATION OF FLUOROPYRROLIDINE DIPEPTIDYL PEPTIDASE-IV INHIBITORS BY RAT LIVER MICROSOMES
Xu, S. S., Zhu, B., Teffera, Y., Pan, D., Caldwell, C. G., Doss, G. A., Stearns, R. A., Evans, D. C., & Beconi, M. G. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.001842 · Cited by 37
Metabolic Profiling of the Novel Hypoxia-Inducible Factor 2α Inhibitor PT2385 In Vivo and In Vitro
Xie, C., Gao, X., Sun, D., Zhang, Y.-B., Krausz, K. W., Qin, X., & Gonzalez, F. J. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.117.079723 · Cited by 37
Drug Discovery and Human African Trypanosomiasis: A Disease Less Neglected?
Ferrins, L., Rahmani, R., & Baell, J. B. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.13.162 · Cited by 36
Lee, H., Doud, E. H., Wu, R., Sanishvili, R., Juncosa, J. I., Liu, D., Kelleher, N. L., & Silverman, R. B. (2015) · Journal of the American Chemical Society · doi:10.1021/ja512299n · Cited by 36
Investigating substrate scope and enantioselectivity of a defluorinase by a stereochemical probe
Wang, J.-B., Ilie, A., Yuan, S., & Reetz, M. T. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b06019 · Cited by 36
Fluorine in psychedelic phenethylamines
Trachsel, D. (2012) · Drug Testing and Analysis · doi:10.1002/dta.413 · Cited by 34
Cited by
Marshall, C. M., Federice, J. G., Bell, C. N., Cox, P. B., & Njardarson, J. T. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c01122 · Cited by 1,064
U.S. FDA Approved Drugs from 2015–June 2020: A Perspective
Bhutani, P., Joshi, G., Raja, N., Bachhav, N., Rajanna, P. K., Bhutani, H., Paul, A. T., & Kumar, R. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01786 · Cited by 815
Dekant, W., & Dekant, R. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03454-y · Cited by 55
Yue, Y., Fan, J., Xin, G., Huang, Q., Wang, J.-B., Li, Y., Zhang, Q., & Wang, W. (2021) · Environmental Science & Technology · doi:10.1021/acs.est.0c08811 · Cited by 50
Metadata
- Authors
- Johnson, B. M., Shu, Y.-Z., Zhuo, X., & Meanwell, N. A.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2020-03-17
- Volume
- 63
- Issue
- 12
- Pages
- 6315-6386
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W3011890716
- Cited by
- 719
- References
- 242
- FWCI
- 68.14
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.